The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Notice of Results

28 Aug 2019 07:00

RNS Number : 3153K
PROACTIS Holdings PLC
28 August 2019
 

Proactis Holdings PLC

Trading Update & Notice of Results

Proactis Holdings PLC, the business spend management solution provider, provides an update on trading for the financial year ended 31 July 2019.

Trading Update

The Group's performance was at the Board's expected levels following the completion of the operational review announced earlier in the year, and it is now focused on delivering the strategy set out at that time. Significant progress has been made and the delivery of the associated benefits are on target. The Board will provide further detail of this progress as part of its final results.

The Board announces that it expects to report an increase in revenue1 to £54.1m (2018: £52.2m) with Adjusted EBITDA1 at £15.0m (2018: £17.3m). Net bank debt2 as at 31 July 2019 has reduced following the generation of £5.1m of adjusted net free cash flow in the second half of the year and is expected to be £36.5m (31 January 2019: £39.3m) and remains fully serviced and within covenants. Adjusted net free cash flow is stated after adding back a net £1.9m of non-recurring cash flows, which relate principally to the non-core costs of restructuring the Group's corporate structure, closure of certain offices and the associated employment costs.

Deal intake for the year was solid and the Group secured a total contract value ("TCV") of £11.3m (2018: £12.1m) from 60 new names (2018: 64) and 127 upsell deals (2018: 120). The Board expects to see an increase in both the number of new name and upsell deals, along with the associated TCV, as benefits of moving toward a consistent go to market strategy for the Group's US, French and German teams are realised.

Following the acquisition of Esize Holdings BV ("Esize") on 6 August 2018, the Board is pleased that the post-acquisition contribution of Esize is in line with expectations with revenue1 of £5.3m and Adjusted EBITDA1 of £1.9m. This level of performance is sufficient to crystallise the full payment of Deferred Consideration as described within the announcement on 7 August 2018 and that is fully provided for within the Group's balance sheet.

Accelerated Payment Facility ("APF")

The Board was delighted to secure a specific committed facility provided by HSBC UK of £20m during the period to support the delivery of the Group's APF. The APF will enable the Group to fund early payments against approved invoices for suppliers. The Board currently anticipates that the product will be deployed in a live environment with the Group's own suppliers during October 2019 before being offered to a number of early adopters.

Formal Sales Process Update ("FSP")

The Board has received a number of expressions of interest following the Company's announcement of the FSP on 29 July 2019 and intends to update shareholders following a careful review of these. As previously expressed, at this early stage, the Board reiterates that there can be no certainty that any offer will be forthcoming or the terms of any such offer.

Notice of Results

The Group currently intends to release its Final Results for the financial year ending 31 July 2019 on 31 October 2019, but this date is subject to change in light of any requirements arising from the FSP described above.

Recognition by Gartner

The Group has again been identified by Gartner Inc. in its Magic Quadrant as one of the top 13 global software vendors for Procure-to-Pay suites, supporting the Group's mission to provide best-in-class spend management solutions. The key criteria for evaluating this recognition include: completeness of vision: market understanding, marketing and sales strategy, product strategy, business model, vertical/industry strategy, innovation and geographic strategy; and ability to execute: product/service capabilities, overall viability, sales execution/pricing, and market responsiveness/track record, marketing execution, operations and customer experience.

 

Tim Sykes, CEO commented:

"We are encouraged by the Group's performance and especially the level of cash generation in the second half of the year. This has reduced net debt substantially and we expect this level of cash flow performance to continue as the Group delivers on the benefits identified during the operational review.

"We have also made significant changes to our management team and processes - the combination of this, along with our current financial performance, offers a stable platform on which the Group can build in order to exploit the considerable opportunities open to it.

"With these opportunities fully determined following our operational review, our teams are deploying their go-to-market and product plans to deliver them on a sustainable and long-term basis. We are excited about the opportunity to replicate our strong performance in the UK and the Netherlands across all of the Group's territories.

"It is extremely pleasing to be able to provide such a positive update on the progress of our APF which is now close to market.

"We approach 2020 with confidence and energy and I am confident that we will be able to demonstrate substantial progress in our business."

 

Revenue and Adjusted EBITDA are unaudited and Adjusted EBITDA is stated before the Company's assessment of non-recurring administrative expenses, amortization of intangible assets and share based payments.

2 Net bank debt is unaudited and is calculated excluding the $3.75 million convertible unsecured loan notes due 2022 and convertible at £1.65 per share arising from the Perfect Commerce acquisition and issued on 4 August 2017, and the €3 million convertible unsecured loan notes due 2023 and convertible at £1.75 per share arising from the esize acquisition and issued on 8 August 2018.

 

This announcement contains inside information for the purposes of article 7 of Regulation 596/2014

 

Financial expectations noted above are unaudited and are subject to the completion of year-end financial close and audit processes.

 

For further information, please contact:

Proactis Holdings PLC

01937 545070 x1115

Tim Sykes, Chief Executive Officer

 

investorcontact@Proactis.com

finnCap Ltd

Stuart Andrews/Henrik Persson/Carl Holmes/Simon Hicks - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

 

0207 220 0500

 

Alma PR

 

Rebecca Sanders-Hewett, Hilary Buchanan, Sam Modlin

 

020 3405 0205

Proactis@almapr.co.uk

Notes to Editors:

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,000 buying organisations around the world from the commercial, public and not-for-profit sectors.

Proactis has been quoted on the AIM market of the London Stock Exchange since June 2006.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUBOVRKVAWUAR
Date   Source Headline
28th Jul 20217:00 amRNSCancellation - Proactis Holdings plc
27th Jul 20213:05 pmRNSScheme Effective
27th Jul 20217:30 amRNSSuspension - Proactis Holdings plc
26th Jul 20218:06 amRNSExercise of Options, PDMR Shareholding & TVR
23rd Jul 20212:25 pmRNSExercise of Options, PDMR Shareholding & TVR
23rd Jul 20212:00 pmRNSCourt Sanction of Scheme & Suspension
21st Jul 20215:30 pmRNSProactis Holdings
20th Jul 20214:25 pmRNSResults of Court Meeting and General Meeting
15th Jul 20213:13 pmRNSHolding(s) in Company
15th Jul 20219:18 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
12th Jul 20211:37 pmRNSForm 8.3 - [PROACTIS HOLDING PLC]
9th Jul 20219:22 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
8th Jul 20219:47 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
1st Jul 20218:28 amRNSForm 8.3 - PROACTIS HOLDINGS PLC
29th Jun 20217:00 amRNSConclusion of cyber security incident
28th Jun 20215:55 pmRNSPosting of Scheme Document
21st Jun 20215:36 pmRNSForm 8 (OPD) Proactis Holdings plc
21st Jun 20217:00 amRNSbePayd Strategic Contract Win
18th Jun 20217:00 amRNSForm 8 (OPD) - Proactis Holdings Plc
11th Jun 20217:11 amRNSUpdate re. Recommended Acquisition of Proactis
11th Jun 20217:00 amRNSRecommended acquisition of Proactis Holdings
28th May 20219:12 amRNSTimetable for publication of the Scheme Document
21st May 20213:37 pmRNSNotice of cyber security incident
18th May 20217:00 amRNSStrategic Contract Win
17th May 20214:58 pmRNSUpdate on irrevocable undertakings
17th May 202111:10 amRNSForm 8.3 - Proactis Holdings plc
17th May 20219:13 amRNSFORM 8 (OPD) - Proactis Holdings Plc
13th May 202110:18 amBUSForm 8.3 - Proactis Holdings Plc
11th May 20215:22 pmRNSHolding(s) in Company
10th May 20213:03 pmRNSForm 8.3 - Proactis Holdings Plc
10th May 20217:00 amRNSForm 8.3 - Proactis Holdings PLC
7th May 202111:57 amRNSForm 8.3 - Proactis Holdings plc
6th May 20215:01 pmRNSForm 8.3 - Proactis Holdings PLC
6th May 202110:54 amRNSForm 8 (OPD) Proactis Holdings plc
5th May 20215:27 pmRNSHolding(s) in Company
5th May 20213:29 pmRNSForm 8.3 - Proactis Holdings Plc
5th May 20212:20 pmRNSForm 8.3 - Proactis Holdings PLC
5th May 202111:47 amRNSForm 8.3 - Proactis plc / Cafe Bidco Limited
4th May 20215:03 pmRNSForm 8.3 - Proactis Holdings Plc
4th May 20214:55 pmRNSHolding(s) in Company
4th May 20212:51 pmRNSForm 8 (DD) - Proactis Holdings Plc
4th May 20211:38 pmRNSForm 8.3 - Proactis / Cafe Bidco Limited
4th May 20211:32 pmRNSForm 8.3 - Proactis / Cafe Bidco Limited
4th May 20219:55 amRNSForm 8.3 - Proactis Holdings Plc
4th May 20217:00 amRNSInvestment in Vertu Motors plc & Notice of Results
30th Apr 20214:40 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20214:24 pmRNSNew LTIP, Grant of Options & PDMR Shareholdings
30th Apr 20214:06 pmRNSRecommended Acquisition of Proactis
30th Apr 20214:00 pmRNSRecommended acquisition of Proactis Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.